Internal Medicine, Medical Oncology · Columbus, OH
NPI
1053564542
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
460 W 10th Ave
Columbus, OH, 43210
Phone (614) 293-0463
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
225 services
Medicare patients, 2024
60
Average age 70
Drug cost, 2024
$934K
223 prescriptions
Company payments, 2025
$12K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gabriel R Tinoco Suarez was code 99215 (office e&m - established), 200 times for 52 patients. In total Gabriel R Tinoco Suarez billed 225 services in 8 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 200 | 52 | $97.45 | $19K |
By year: 2022 $25K for 250 services; 2023 $21K for 214 services; 2024 $22K for 225 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gabriel R Tinoco Suarez prescribed most often to Medicare patients was Imatinib Mesylate, with 30 prescriptions and refills. In total Gabriel R Tinoco Suarez wrote 223 Medicare prescriptions that cost $934K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 30 | 30 | Under 11 | $49K |
| Ogsiveo Nirogacestat Hydrobromide | 24 | 24 | Under 11 | $660K |
| Votrient Pazopanib Hcl | 14 | 14 | Under 11 | $94K |
| Gabapentin Generic | 13 | 13 | Under 11 | $118 |
| Prochlorperazine Maleate Generic | 13 | 13 | Under 11 | $165 |
Brand drugs: 56 claims; generic drugs: 167 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gabriel R Tinoco Suarez $12K ($12K in general payments such as food, travel and fees) from 6 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $5,468.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.